Skip to main content
Premium Trial:

Request an Annual Quote

Rheonix Gets $12.6M in Series A Funding Round

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rheonix, an Ithaca, NY-based molecular diagnostics startup, has raised $12.6 million in a Series A round of funding.

The firm said that it would use the proceeds to continue development of the Rheonix Chemistry and Reagent Device system, an end-to-end molecular diagnostics instrument that includes raw sample preparation, molecular amplification, and multiplex analysis. It said that the system enables end users to automate new or existing assays using single or multiple raw clinical samples.

"The Rheonix CARD system provides a simple solution for partners who seek to incorporate complex, high-throughput molecular diagnostics into their routine research and development efforts," Rheonix President and CEO Tony Eisenhut said in a statement. "With this funding, we will focus on scaling the Rheonix CARD system to demonstrate the full commercial potential of our platform."

The firm said that the disposable Rheonic CARD technology can be customized for immunoassay, pathogen identification, gene sequence detection, cell-based assays, and other molecular diagnostic applications.

The Series A funding was provided by a syndicate of regional and international firms, which was led by the Cayuga Venture Fund and Bill and Eric Allyn, said Rheonix.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.